Christine Ring
2021
In 2021, Christine Ring earned a total compensation of $1.6M as General Counsel and Secretary at Nurix Therapeutics, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,620 |
|---|---|
| Option Awards | $1,053,065 |
| Salary | $413,750 |
| Other | $4,460 |
| Total | $1,648,895 |
Ring received $1.1M in option awards, accounting for 64% of the total pay in 2021.
Ring also received $177.6K in non-equity incentive plan, $413.8K in salary and $4.5K in other compensation.
Rankings
In 2021, Christine Ring's compensation ranked 6,838th out of 12,406 executives tracked by ExecPay. In other words, Ring earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,838 out of 12,406 | 45th |
Division Manufacturing | 2,976 out of 5,494 | 46th |
Major group Chemicals And Allied Products | 1,318 out of 2,369 | 44th |
Industry group Drugs | 1,175 out of 2,090 | 44th |
Industry Pharmaceutical Preparations | 856 out of 1,537 | 44th |
Source: SEC filing on March 25, 2022.
Ring's colleagues
We found four more compensation records of executives who worked with Christine Ring at Nurix Therapeutics in 2021.